封面
市場調查報告書
商品編碼
1679362

全球體外診斷市場:市場規模、佔有率、趨勢分析(按產品、測試地點、最終用途、應用、技術和地區)、細分市場預測(2025-2030 年)

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End Use, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10個工作天內

價格

體外診斷市場的成長與趨勢:

預計到 2030 年全球體外診斷市場規模將達到 1,501.3 億美元,2025 年至 2030 年的複合年成長率為 5.62%。

老年人口的成長、新冠肺炎疫情以及診斷技術的進步推動了它的廣泛應用。便攜性、準確性和成本效益的技術進步預計將成為渲染影響的最大促進因素。隨著新冠肺炎體外(IVD)診斷技術的推出,技術進步進一步加速,PCR等技術的設備和耗材的使用也得到加強。該市場的競爭對手擴大採用合約和夥伴關係策略來確保製造商和用戶之間的業務穩定流動。

這些合約也是政府實驗室採取嚴格的價格控制策略的結果,降低了政府環境下的價格。例如,2021 年 4 月,Seegene 公司義大利子公司獲得了價值 1.0825 億美元的公共採購競標,用於供應萃取試劑以及 715 萬個 SARS-CoV-2 診斷測試。 SARS-CoV-2 診斷檢測的主要目的是供應 SARS-CoV-2 診斷檢測試劑和 SARS-CoV-2 萃取試劑,這增加了供應鏈的多方貿易和複雜性。全球癌症和心血管疾病(CVD)的高發性預計將推動診斷創新,以促進早期診斷並滿足消費者不斷變化的需求。預計等離子體 PCR 等新技術將在預測期內商業性進入市場,對現有產品的業務產生不利影響。

體外診斷市場:分析概述

  • 體外診斷(IVD)市場表現出高度的技術創新,這得益於分子診斷、次世代定序(NGS)和PoC測試的進步。
  • 體外診斷(IVD)市場的分銷管道在產品如何到達醫療機構、實驗室和最終用戶方面發揮著至關重要的作用,影響市場覆蓋率和業務效率。
  • 體外診斷(IVD)產品的定價根據產品類型、複雜性和應用而有很大差異。
  • 到 2024 年,試劑將佔據體外診斷市場的最大佔有率,達到 65.54%,這主要得益於領先市場參與者開發創新生物標記試劑套件的研發努力。
  • 北美在體外診斷產業佔據主導地位,2024 年的佔有率為 47.43%。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章體外診斷市場:促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 市場機會分析
    • 供應鏈分析
    • 分銷管道
  • 體外診斷市場:分析工具
    • 產業分析:波特五力分析
    • PESTEL 分析
  • IVD 和 LDT 報銷:概述
  • 定價分析

第 4 章體外診斷市場:按產品分類的估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場:按產品分類的趨勢分析(2024 年和 2030 年)
  • 裝置
  • 設備:市場收益估計與預測(金額(十億美元)、數量(千台),2018 年至 2030 年)
  • 試劑
  • 服務

第 5 章體外診斷市場:按技術分類的估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場:依技術分類的趨勢分析(2024 年和 2030 年)
  • 免疫檢測
    • 裝置
    • 試劑
    • 服務
  • 血液學
    • 裝置
    • 試劑
    • 服務
  • 臨床化學
    • 裝置
    • 試劑
    • 服務
  • 分子診斷
    • 裝置
    • 試劑
    • 服務
  • 凝血
    • 裝置
    • 試劑
    • 服務
  • 微生物
    • 裝置
    • 試劑
    • 服務
  • 其他
    • 裝置
    • 試劑
    • 服務

第 6 章體外診斷市場:按應用分類的估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場:按應用分類的趨勢分析(2024 年和 2030 年)
  • 感染疾病
  • 糖尿病
  • 腫瘤學/癌症
  • 心臟病學
  • 腎臟病學
  • 自體免疫疾病
  • 藥物檢測
  • 其他

第 7 章體外診斷市場:按測試地點進行的估計和趨勢分析

  • 細分儀表板
  • 體外診斷市場:按測試地點分類的趨勢分析(2024 年和 2030 年)
  • 照護現場
  • 居家醫療
  • 其他

第 8 章體外診斷市場:依最終用途的估計與趨勢分析

  • 細分儀表板
  • 體外診斷市場:趨勢分析,依最終用途(2024 年和 2030 年)
  • 醫院
  • 實驗室
  • 居家醫療
  • 其他

第 9 章體外診斷市場:按地區分類的估計和趨勢分析

  • 各地區體外診斷市場佔有率(十億美元,2024 年和 2030 年)
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢及影響分析
  • 公司分類
  • 全球公司市場佔有率分析(2024 年)
  • 公司熱圖分析
  • 戰略地圖
    • 擴張
    • 企業合併與收購 (M&A)
    • 夥伴關係和合作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
  • The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
  • The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
  • Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
  • North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Introduction of Technologically Advanced Products
      • 3.2.1.2. Increasing Demand for PoC Testing
      • 3.2.1.3. Growing Prevalence of Target Diseases
      • 3.2.1.4. Increasing External Funding for R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. High Capital Investment
      • 3.2.2.3. High Prices of Molecular Diagnostic Tests
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
    • 3.2.5. Distribution Channel
      • 3.2.5.1. Direct Sales
      • 3.2.5.2. Distributors Network
      • 3.2.5.3. E-commerce and Online Platforms
      • 3.2.5.4. Major Distributors
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Reimbursement Overview of IVDs and LDTs
  • 3.5. Pricing Analysis

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Instruments
  • 4.4. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Units)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030, USD Billion
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.2. U.K.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Bio-Rad Laboratories, Inc
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. BIOMERIEUX
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. BD
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. QIAGEN
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. F. Hoffmann-La Roche Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Danaher
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Quest Diagnostics Incorporated
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Agilent Technologies, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 USD Billion
  • Table 8 Global In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 North America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 U.S. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Canada In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 29 Mexico In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 35 Europe In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 37 U.K. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 39 U.K. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 U.K. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Germany America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 France In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Spain In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 59 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 60 Italy In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 66 Asia-Pacific In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 71 China In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 76 Japan In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 81 India In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 86 South Korea In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 88 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 89 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 90 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 91 Australia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 93 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 94 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 96 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 97 Latin America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 99 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 101 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 102 Brazil In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 104 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 106 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 107 Argentina In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 109 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 110 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 111 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 112 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 MEA In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 115 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 117 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 118 South Africa In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 120 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 121 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 122 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 123 UAE In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion) million
  • Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 128 Saudi Arabia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2024
  • Fig. 11 In vitro diagnostic market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostic market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 IVD market: Product outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 21 Reagents market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology movement analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 28 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hematology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 31 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 32 Services market for hematology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Coagulation market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 44 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 48 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Others market estimates and forecast, 2018 - 2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
  • Fig. 50 Instruments others market estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 51 Reagents others market estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 52 Services market for other technology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Drug testing market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 IVD market: End Use outlook and key takeaways
  • Fig. 64 IVD treatment market: End Use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 66 Laboratory market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 67 Home care market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 68 Other market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 69 IVD market: test location outlook and key takeaways
  • Fig. 70 IVD treatment market: Test location movement analysis
  • Fig. 71 Point-of-care market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Homecare market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 IVD Market: Regional outlook and key takeaways
  • Fig. 75 IVD market: Regional movement analysis
  • Fig. 76 North America
  • Fig. 77 North America. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 86 U.K. key country dynamics
  • Fig. 87 U.K. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 90 Spain key country dynamics
  • Fig. 91 Spain market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 104 Japan key country dynamics
  • Fig. 105 Japan market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 106 China key country dynamics
  • Fig. 107 China. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 108 India key country dynamics
  • Fig. 109 India. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 112 Thailand key country dynamics
  • Fig. 113 Thailand market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 122 MEA
  • Fig. 123 MEA market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 126 UAE key country dynamics
  • Fig. 127 UAE market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 128 Saudi Arabia key country dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 130 Ansoff matrix
  • Fig. 131 Competition categorization
  • Fig. 132 Company market share analysis, 2024
  • Fig. 133 Global mass spectrometry company market share analysis, 2024
  • Fig. 134 North America mass spectrometry company market share analysis, 2024
  • Fig. 135 Europe mass spectrometry company market share analysis, 2024
  • Fig. 136 Asia Pacific mass spectrometry company market share analysis, 2024
  • Fig. 137 Global immunoassay company market share analysis, 2024
  • Fig. 138 North America immunoassay company market share analysis, 2024
  • Fig. 139 Europe immunoassay company market share analysis, 2024
  • Fig. 140 Asia Pacific immunoassay company market share analysis, 2024
  • Fig. 141 Global PCR company market share analysis, 2024
  • Fig. 142 North America PCR company market share analysis, 2024
  • Fig. 143 Europe PCR company market share analysis, 2024
  • Fig. 144 Asia Pacific PCR company market share analysis, 2024
  • Fig. 145 Company market position analysis
  • Fig. 146 Company market position analysis
  • Fig. 147 Company market position analysis
  • Fig. 148 Company profiles
  • Fig. 149 Regional network map